Place of iron chelators like desferrioxamine and deferasirox in management of hyperoxia-induced lung injury; a systematic review

International Journal of Pharmacology

Volumn 6, Issue 4, 2010, Pages 397-408

  Mousavi, Sarah ^a   Mojtahedzadeh, Mojtaba ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Deferasirox; Desferoxamine; Hyperoxia induced lung injury; Iron chelator; Oxidative stress; Systematic review

Indexed keywords

ACETYLCYSTEINE; ACTIVATED PROTEIN C; ALLOPURINOL; AZITHROMYCIN; CAPTOPRIL; CLARITHROMYCIN; CYCLOSPORIN A; DEFERASIROX; DEFEROXAMINE; DEXAMETHASONE; ESCHERICHIA COLI ENDOTOXIN; IBUPROFEN; IRON CHELATING AGENT; KERATINOCYTE GROWTH FACTOR; LISOFYLLINE; MELATONIN; MONTELUKAST; N TERT BUTYL ALPHA PHENYLNITRONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTOXIFYLLINE; PROPYLTHIOURACIL; PROSTAGLANDIN E1; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT VASCULOTROPIN; RETINOIC ACID; ROSIGLITAZONE; SILDENAFIL; SUPEROXIDE DISMUTASE; UNINDEXED DRUG;

ARTICLE; BONE MARROW TRANSPLANTATION; CATALYSIS; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG TARGETING; HUMAN; HYPEROXIA; IRON CHELATION; IRON OVERLOAD; IRON TRANSPORT; LOW DRUG DOSE; LUNG INJURY; LUNG INSUFFICIENCY; MEDIATOR RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; RISK BENEFIT ANALYSIS; STROMA CELL; SYSTEMATIC REVIEW;

EID: 77955621236     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.326.337     Document Type: Article

References (124)

1. Abdollahi, M., A.R. Dehpour and F. Shafayee, 2000a. L-Arginine/nitric oxide pathway and interaction with lead acetate on rat submandibulary gland function. Pharmacol. Toxicol., 87: 198-203.
2. Abdollahi, M., A.R. Dehpour and P. Kazemian, 2000b. Interaction of cadmium with nitric oxide in rat submandibulary gland function. Pharmacol. Res., 42: 591-597.
3. Abdollahi, M., A. Ranjbar, S. Shadnia, S. Nikfar and A. Rezaiee, 2004. Pesticides and oxidative stress: A review. Med. Sci. Monit., 10: 141-147.
4. Ahmad, A., S. Ahmad, L.Y. Chang, J. Schaack and C.W. White, 2006. Endothelial Akt activation by hyperoxia: Role in cell survival. Free Radic. Biol. Med., 40: 1108-1118.
5. Ansari, G., M. Mojtahedzadeh, F. Kajbaf, A. Najafi and M.R. Khajavi et al., 2008. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines. Adv. Ther.,25: 681-702.
6. Aslam, M., R. Baveja, O.D. Liang, A. Fernandez-Gonzalez, C. Lee, S.A. Mitsialis and S. Kourembanas, 2009. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am. J. Respir. Crit. Care Med., 11: 1122-1130.
7. Auten, Jr. R.L., S.N. Mason, D.T. Tanaka, K. Welty-Wolf and M.H. Whorton, 2001. Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am. J. Physiol. Lung Cell Mol. Physiol., 281:L336-L344.
8. Avissar, N., J.N. Finkelstein, S. Horowitz, J.C. Willey and E. Coy et al., 1996. Extracellular glutathione peroxidase in human lung epithelial lining fluid and in lung cells. Am. J. Physiol., 14: L173-L182.
9. Baba, Y., T. Yazawa, Y. Kanegae, S. Sakamoto and I. Saito et al., 2007. Keratinocyte growth factor gene transduction ameliorates acute lung injury and mortality in mice. Human Gene. Ther., 18: 130-141.
10. Babior, B.M., L.D. Lambeth and W. Nauseef, 2002. The neutrophil NADPH oxidase. Arch. Biochem. Biophys., 397: 342-344.
11. Ballard, H.O., P. Bernard, J. Quails, W. Everson and L.A. Shook, 2007. Azithromycin protects against hyperoxic lung injury in neonatal rats. J. Investig. Med., 55: 299-305.
12. Beckett, W.S. and N.D. Wong, 1988. Effect of normobaric hyperoxia on airways of normal subjects. J. Applied Physiol., 64: 1683-1687.
13. Berg, T.J., 2006. Zymosan priming protects rats against pulmonary oxygen toxicity. Inflamm. Res., 55: 565-571.
14. Birgens, H.S., L.O. Kristensen, N. Borregaard, H. Karle and H.E. Hansen, 1998. Lactoferrin-mediated transfer of iron to intracellular ferritin in human monocytes. Eur. J. Haematol., 41: 52-57.
15. Bogdan, C., 2001. Nitric oxide and immune response. Nat. Immunol. Med., 2: 907-916.
16. Bryan, C.L., R.E. Lewis, S.L. Owens, B. Emanuel and G. Jekinson, 1993. Allopurinol inhibition of neutrophilic alveolar response during hyperoxia. J. Applied Physiol., 75: 357-363.
17. Cantin, A.M., G.A. Fells, R.C. Hubbard and R.G. Crystal, 1999. Antioxidant macromolecules in the epithelial lining fluid of normal human lower respiratory tract. J. Clin. Invest., 86: 962-971.
18. Cellier, M., G. Prive, A. Belouchi, T. Kwan, V. Rodrigues, W. Chia and P. Gros, 1995. Nramp defines a family of membrane proteins. Proc. Nat. Acad. Sci. USA., 92: 10089-10093.
19. Chakraborti, S., S.K. Batabyal and T. Chakraborti, 1999. Role of vitamin C in ameliorating lung damage in response to hyperoxia in developing newborn guinea pig. Med. Sci. Res., 27: 41-43.
20. Chang, L.L., M. Subramaniam, B.A. Yoder, B.J. Day, M.C. Ellison, M.E. Sunday and J.D. Crapo, 2003. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am. J. Respir. Cnt. Care Med., 167: 57-64.
21. Chang, Y.S., Y.J. Kim, H.S. Yoo, D.K. Sung, S.Y. Kim, S. Kang and W.S. Park, 2009. Alpha-phenyl-N-tert-butylnitrone attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats. Exp. Lung. Res., 35: 234-249.
22. Chung-Wai, C., M.T.H. Abreu, T. Suzuki and G.P. Downey, 2003. Oxidative stress and acute lung injury. Am. J. Respir. Cell Mol. Biol., 29: 427-431.
23. Ciencewicki, J., S. Trivedi and S.R. Kleeberger, 2008. Oxidants and the pathogenesis of lung diseases. J. Allergy Clin. Immunol., 122: 456-468.
24. Cross, C.E., A. van der Vliet, C.A. O'Neill, S. Louie and B. Halliwell, 1994. Oxidants, antioxidants and respiratory tract lining fluids. Environ. Health Perspect., 102: 185-191.
25. Das, D.K., D. Bandyopadyay, S. Hoory and H. Steinberg, 1988. Role of polymorphonuclear leukocytes in hyperoxic lung injury. Prevention of neutrophil influx into the lung endothelium during oxygen exposure by ibuprofen. Biomed. Biochim. Acta., 47: 1023-1036.
26. Davis, W.B., S.I. Rennard, P.B. Bitterman and R.G. Ciystal, 1983. Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. NEJM., 309: 878-883.
27. Davies, K.J., A. Sevanian, S.F. Muakkassah-kelly and P. Hochstein, 1986. Uric acid-iron ion complexes. A new aspect of the antioxidant function of uric acid. Biochem. J., 235: 747-754.
28. Davis, J.M., W.N. Rosenfeld, R.J. Sanders and A. Gonenne, 1993. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J. Applied Physiol., 74: 2234-2241.
29. De Visser, Y.P., F J. Walther, H. El-Laghmani, H. Boersma, A. van der Laarse and G.T. Wagenaar, 2009. Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir. Res., 109: 30-46.
30. Deboer, D.A. and R.E. Clark, 1992. Iron chelation in myocardial preservation after ischemia-reperfusion injury: The importance of pretreatment and toxicity. Ann. Thorac. Surg., 53: 412-418.
31. Demir, K., A. Kumral, N. Duman, S. Sarioglu, O.Yilmaz, D.C. Yesilirmak, A. Kargi and H. Ozkan, 2008. Clarithromycin, montelukast and pentoxifylline combination treatment ameliorates experimental neonatal hyperoxic lung injury. Matern. Fetal Neonatal Med., 21: 407-413.
32. Dennery, P., D. Spitz, G. Yang, A. Tatarov, C.H. Lee and M. Shegog, 1998. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J. Clm. Invest., 101: 1001-1011.
33. Drossos, G., A. Lazou, P. Panagopoulos and S. Westaby, 1995. Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann. Thorac. Surg., 59: 169-172.
34. Du, J., A.L.Z. Du, J J Jiang, L.F. Tang and X.L. Wu, 2006. Effect of inhaled nitric oxide on surfactant protein A and mannose binding ability in the lung of neonatal rats with hyperoxia-induced lung injury. Zhongguo Dang Dai Er Ke Za Zhi., 8: 486-490.
35. Eisenstein, R.S., 2000. Iron ragulatory proteins and the molecular control of mammalian iron metabolism. Annu. Rev. Nutr., 20: 627-662.
36. Emerit, J., C. Beaumont and F. Trivin, 2001. Iron metabolism, free radicals and oxidative injury. Biomed. Pharmacother., 55: 333-339.
37. Fogg, S., A. Agrawal, H. Nick and G. Visner, 1999. Iron regulates hyperoxia-dependent human Heme oxygenase 1 gene expression in pulmonary endothelial cell. Am. J. Respir. Cell Mol. Biol., 20: 794-804.
38. George, C.L., G. Fantuzzi, S. Bursten, L. Leer and E. Abraham, 1999. Effects of lisofylline on hyperoxia-induced lung injury. Am. J. Physiol., 276: L776-L785.
39. Ghio, A.J., P.J. Fracica, S.L. Young and C.A. Piantadosi, 1994. Synthetic surfactant scavenges oxidants and protects against hyperoxic lung injury. J. Applied Physiol., 77: 1217-1223.
40. Ghio, A., J. Carter, J. Richards, L. Brighton, J. Lay and R. Delvin, 1998. Disruption of normal iron homestasis after bronchial instillation of an iron-containing particle. Am. J. Physiol. Lung Cell Mol. Physiol., 274: L396-L403.
41. Ghio, A., E. Eozik-Grayck, J. Turi, I. Jaspers, D.R. Mercatante, R. Kole and C. Piantadosi, 2003. Superoxide-dependent iron uptake: A new role for anion exchange protein 2. Am. J. Respir. Cell Mol. Biol., 29: 653-660.
42. Ghio, A., 2009. Disruption of iron homeostasis and lung disease. Biochem. Biophys. Acta, 1790: 731-739.
43. Hageman, J.R., S.E. Lee, J. Zemaitis, L.J. Smith and C.E. Hunt, 1989. Prostaglandin El infusion fails to prevent hyperoxic lung injury in adult rabbits. Crit. Care Med., 17: 339-344.
44. Hallman, M., A. Sarnesto and K. Bry, 1994. Interaction of transferrin saturated with iron with lung surfactant in respiratory failure. J. Applied Physiol., 77: 757-766.
45. Harrison, P.M and P. Arosio, 1996. The ferritins: Molecular properties, iron storage, function and cellular regulation. Biochem. Biophys. Acta, 1275: 161-203.
46. Hershko, C., 1992. Iron chelators in medicine. Mol. Aspects Med., 45: 276-281.
47. Hershko, C., 1994. Control of disease by selective iron depletion: A novel therapeutic strategy utilizing iron chelators. Baillieres Clin. Haematol., 7: 965-1000.
48. Jenkinson, S.G., R.J. Roberts, R.A. de Lemos, R.A. Lawrence and J.J. Coalson et al, 1991. Allopurinol-induced effects in premature baboons with respiratory distress syndrome. J. Applied Physiol., 70: 1160-1167.
49. Kajbaf, F., M. Mojtahedzadeh and M. Abdollahi, 2007. Mechanisms underlying stress-induced hyperglycemia in critically ill patients. Therapy, 4: 97-106.
50. Kontoghioghes, G.J., A. Kolnagou, C.T. Peng, S.V. Shah and A. Aessopos, 2010. Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases. Expert. Opin. Drug Saf., 9: 201-206.
51. Kunig, A.M., V. Balasubramaniam, N.E. Markham, D. Morgan, G. Montgomery, T.R. Grover and S.H. Abman, 2005. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am. J. Physiol. Lung Cell Mol. Physiol., 289: L529-L535.
52. Ladha, F., S. Bonnet, F. Eaton, K. Hashimoto, G. Korbutt and B. Thebaud, 2005. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am. J. Respir. Crit. Care Med., 172: 750-756.
53. Lalonde, C., K. Ikegani and R. Demling, 1994. Aerosolized deferoxamine prevents lung and systemic injury caused by smoke inhalation. J. Applied Physiol., 77: 2057-2064.
54. Langley, S.C. and F.J. Kelly, 1993. N-acetylcysteine ameliorates hyperoxic lung injury in the preterm guinea pig. Biochem. Pharmacol., 45: 841-846.
55. Lavaute, T., S. Smith, S. Cooperman, K. Iwai, E. Meyron-Holtz, S.K. Drake and G. Mitter, 2001. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet., 27: 209-214.
56. Lee, P.L., T. Gelbart, C. West, C. Halloran and E. Beutler, 1998. The human Nramp 2 gene: Characterization of the gene structure, alternative splicing, promotor region and polymorphisms. Blood Cells Mol. Dis., 24: 199-215.
57. Lee, P.J. and A.M. Choi, 2003. Pathways of cell signaling in hyperoxia. Free Radic. Biol. Med., 34: 341-350.
58. Lee, J.H., D.K. Sung, S.H. Koo, B.K. Shin and Y.S. Hong et al, 2007. Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats. J. Korean Med. Sci., 22: 1042-1047.
59. Li, L.F., S.H. Liao, Y.S. Ko, C.H. Lee and D. Quinn, 2007. Hyperoxia increases ventilators-induced lung injury via mitogen-activated protein kinases, a prospective controlled animal experiment. Crit. Care, 11: R25-R25.
60. Li, W.B., L.W. Chang, Z.H. Rong, H.C. Liu and Q.S. Zhang et al, 2008. Retinoic acid diminished the expression of lung tissue matrix metalloproteinase-2 and matrix metalloproteinase-9 in hyperoxia-exposed premature rats through regulating mitog en-activated protein kinases. Zhonghua Er Ke Za Zhi., 46: 347-353.
61. Lloyd, R.V., P.M. Hanna, P.M. and R.P. Mason, 1997. The origin of the hydroxyl radical in the Fenton reaction. Free Radic. Biol. Med., 22: 885-888.
62. Looney, M.R., C.T. Esmon and M.A. Matthay, 2009. Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury. Thorax, 64: 114-120.
63. Lyer, S. and B. Lonnerdal, 1993. Lactoferrin, lactoferrin receptors and iron metabolism. Eur. J. Clin. Nutr., 47: 232-241.
64. Mahmoodpoor, A., M. Mojtahedzadeh, A. Najafi, A. Ahmadi and A. Dehnadi-Moghadam et al., 2010. Examination of setarud (IMOD™) in the management of patients with severe sepsis. DARU, 18: 23-28.
65. Maines, M.D., 1988. Heme oxygenase: Function, multiplicity, regulatory mechanisms and clinical applications. FASEB J., 2: 2557-2568.
66. Mateos, F., J. Brock and J. Perez-Arellano, 1998. Iron metabolism in the lower respiratory tract. Thorax, 53: 594-600.
67. Matthew, E., L. Kutcher and J. Dedman, 2003. Protection of lungs from hyperoxic injury: Gene expression analysis of cyclosporin A therapy. Physiol. Genomics., 14: 129-138.
68. McCoubrey, W.K., T.J. Huang and M.D. Maines, 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase 3. Eur. J. Biochem., 274: 725-732.
69. Menasche, P., C. Grousset, Y. Gauduel, C. Mouas and A. Piwnica, 1987. Prevention of hydroxyl radical formation: A critical concept for improving cardioplegia. Protective effect of deferoxamine. Circulation, 76: V180-V185.
70. Mikawa, K., K. Nishina, N. Maekawa and H. Obara, 1995. Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase: Effects on inflammatory mediators. Acta Anaesthesiol. Scand., 39: 317-322.
71. Mojtahedzadeh, M., M.R. Rouini, F. Kajbaf, A. Najafi, G. Ansari, A. Gholipour, A.R. Mofid 2008. Advantage of adjunct metformin and insulin therapy in the management of glycemia in critically ill patients. Evidence for nonoccurrence of lactic acidosis and needing to parenteral metformin. Arch. Med. Sci., 4: 174-178.
72. Najafi, A., M. Mojtahedzadeh, A. Mahmoodpoor, M. Aghamohammadi and A. Ahmadi et al., 2009. Effect of N-acetylcysteine on microalbuminuria in patients with acute respiratory distress syndrome. Arch. Med. Sci., 5: 408-414.
73. Naureckas, E.T., P. Factor, O. Benjaminov, E. Hoffer, V. Sriram and J.I. Sznajder, 1994. Pentoxifylline does not protect against hyperoxic lung injury in rats. Eur. Respir. J., 7: 1397-1402.
74. Nelson, S.K. and J.M. McCord, 1998. Iron, oxygen radicals and disease. Adv. Mol. Cell. Biol., 25: 157-183.
75. Obara, H., S. Iwai and T. Takada, 1985. The effect of a high dose of vitamin E on the oxygen injured lung. Masui, 34: 286-291.
76. Omar, R, I. Nomikos, G. Piccorelli, J. Savino and N. Agrawal, 1989. Prevention of postischemic lipid peroxidation and liver cell injury by iron chelation. Gut, 30: 510-514.
77. Ozer, E.A., A. Kumral, E. Ozer, O. Yilmaz and N. Duman et al., 2005. Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr. Res., 58: 38-41.
78. Pagano, A., Y. Donati, I. Métrailler and C.B. Argiroffo, 2004. Mitochondrial cytochrome c release is a key event in hyperoxia-induced lung injury: Protection by cyclosporin A. Am. J. Physiol. Lung. Cell Mol. Physiol., 286: L275-L283.
79. Paine, R., S.E. Wilcoxen, S.B. Morris, C. Sartori, C.E. Baleeiro, M.A. Matthay and P.J. Christensen, 2003. Transgenic over express ion of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury. Am. J. Pathol., 163: 2397-2406.
80. Pan, L., J.H. Fu, X.D. Xue, W. Xu, P. Zhou and B. Wei, 2009. Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia. World J. Pediatr., 5: 216-221.
81. Pantarulo, S., 2005. Iron, oxidative stress and human health. Mol. Aspects Med., 26: 299-312.
82. Pantopoulos, K. and M.W. Hentz, 1998. Activation of iron regulatory protein-1 by oxidative stress in vitro. Proc. Nat. Acad. Sci. USA., 95: 10559-10563.
83. Papanikolaou, G. and K. Pantopoulos, 2005. Iron metabolism and toxicity. Toxicol. Applied Pharmacol., 202: 199-211.
84. Paraskevaidis, I.A., E.K. Lliodromitis, D. Vlahakos, D. Tsiapras and A. Nikolaidis et al., 2005. Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: imediate and long-term significance. Eur. Heart J., 26: 263-270.
85. Pedan, D.B., M. Swiersz, K. Ohkubo, B. Hahn, B. Emery and M.A. Kaliner, 1993. Nasal secretion of ozone scavenger uric acid. Am. Rev. Respir. Dis., 148: 455-461.
86. Pinhoa, R.A., P.C.L. Silveirab, L.A. Silvab, E.L. Streckc, F. Dal-Pizzold and J.C.F. Moreira, 2005. N-acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. Environ. Res., 99: 355-360.
87. Prass, K., K. Ruscher, M. Karsch, N. Isaev and D. Megow et al., 2002. Desferoxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab., 22: 520-525.
88. Quinn, D.A., R.K. Moufarrej, A. Volokhov and C.A. Hales, 2002. Interactions of lung stretch, hyperoxia and MIP-2 production in ventilator-induced lung injury. J. Applied Physiol., 93: 517-525.
89. Radomski, A., G. Sawicki, D.M. Olson and M.W. Radomski, 1998. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br. J. Pharmacol., 125: 1455-1462.
90. Ramsay, P.L., B. Piedboeuf, M. Gamache, R.S. Geske, C.V. Smith and S.E. Welty, 2000. Dexamethasone enhances P-selectin mRNA expression in hyperoxic rat lungs. Inflamm. Res., 49: 655-665.
91. Rehan, V.K., Y. Wang, S. Patel, J. Santos and J.S. Torday, 2006. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr. Pulmonol., 41: 558-569.
92. Reynolds, P.R., R.E. Schmitt, S.D. Kasteler, A. Sturrock and K. Sanders et al, 2010. Receptors for advanced glycation end-products (RAGE) targeting protect against hyperoxia-induced lung injury in mice. Am. J. Respir. Cell Mol. Biol., 42: 545-551.
93. Rezaie, A., R.D. Parker and M. Abdollahi, 2007. Oxidative stress and pathogenesis of inflammatory bowel disease: An epiphenomenon or the cause? Dig. Dis. Sci., 52: 2015-2021.
94. Ritter, C., A.A. da Cunha, I.C. Echer, M. Andrades and A. Reinke et al, 2006. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit. Care Med., 34: 471-477.
95. Rodriguez-Pierce, M., I.R. Sosenko, P. Whitney and L. Frank, 1994. Propylthiouracil treatment decreases the susceptibility to oxygen radical-induced lung damage in newborn rats exposed to prolonged hyperoxia. Pediatr. Res., 35: 530-535.
96. Romashko, J., S. Horowitz, W.R. Franek, T. Palaia and E.J. Miller et al, 2003. MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells. Free Radic. Biol. Med., 35: 978-993.
97. Salari, P., M. Mojtahedzadeh and M. Abdollahi, 2005a. Influence of serum epidermal growth factor on mechanical ventilation and survival in patients with acute respiratory distress syndrome. Therapy, 2: 393-398.
98. Salari, P., M. Mojtahedzadeh, A. Najafi, S. Sadraie, K. Bahaadini, M. Moharreri, N. Hadavandand M. Abdollahi, 2005b. Comparison of the effect of aminophylline and low PEEP vs. high PEEP on EGF concentration in critically ill patients with ALI/ARDS. J. Clin. Pharmacy Therapeutics, 30: 139-144.
99. Shim, J.W., Y.S. Chang and W.S. Park, 2008. Intratracheal administration of endotoxin attenuates hyperoxia-induced lung injury in neonatal rats. Yonsei Med. J., 49: 144-150.
100. Soltan-Sharifi, M.S., M. Mojtahedzadeh, A. Najafi, M.R. Khajavi and M.R. Rouini, 2007. Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione and extracellular thiol molecules and antioxidant power: Evidence for underlying toxicological mechanisms. Human Exp. Toxicol., 26: 697-703.
101. Sprang, C., Y.M.W. Janssen and P.J.A. Bonn, 1991. The role of reactive oxygen species, cytokines and cytochrome P450 in pulmonary damage due to hyperoxia. Med. Hypotheses., 34: 296-299.
102. Stumpf, J., 2007. Deferasirox. Am. J. Health-Syst. Pharm., 64: 606-616.
103. Su, W.Y., R. Folz, J.S. Chen, D.J. Capro and L.Y. Chang, 1997. Extacellular superoxide dismutase mRNA expressions in human lung by in situ hybridization. Am. J. Respir. Cell Mol. Biol., 16: 162-170.
104. Ter Horst, S.A., G.T. Wagenaar, E. de Boer, M.A. van Gastelen and J.C. Meijers et al, 2004. Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury. J. Applied Physiol., 97: 2014-2019.
105. Thomson, A.M., J.T. Rogers and P.J. Leedman, 1999. Iron regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int. J. Biochem. Cell Biol., 31: 1139-1152.
106. Torti, F. and S. Torti, 2002. Regulation of ferritin genes and proteins. Blood, 99: 3505-3516.
107. Town, G.I., G.J. Phillips, M. Landreau, J. Louden, S.T. Holgate and F.J. Kelly, 1993. Dexamethasone treatment fails to reduce oxygen-induced lung injury in the preterm guinea pig. Effects on pulmonary inflammation and antioxidant status. Biochem. Pharmacol., 46: 1565-1572.
108. Turi, J., F. Yang, M. Garrick, C. Piantadosi and A. Ghio, 2004. The iron cycle and oxidative stress in the lung. Free Radic. Biol. Med., 36: 850-857.
109. Van der Vliet, A., C.E. Cross and C.A. O'Neill, 1999. Determination of low-molecular mass antioxidant concentrations in human respiratory tract lining fluids. Am. J. Physiol., 276: L289-L296.
110. Van Klaveren, R.J., D. Dinsdale, J.L. Pype, M. Demedts and B. Nemery, 1997. N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats. Am. J. Physiol., 273: L548-L555.
111. Van Snick, J.L., B. Markowetz and P.L. Masson, 1977. The ingestion and digestion of human lactoferrin by mouse peritoneal macrophages and the transfer of its iron into ferritin. J. Exp. Med., 146: 817-827.
112. Vanorden, H. and T. Hagemann, 2006. Deferasirox an oral agent for chronic iron overload. Ann. Phamacother., 40: 1110-1117.
113. Vazin, A., M. Mojtahedzadeh, A. Najafi, A. Khalilzadeh and M. Abdollahi, 2005a. Relationship between duration, fatality rate and severity of disease and serum epidermal growth factor in human acute lung injury. Therapy, 2: 255-259.
114. Vazin, A., M. Mojtahedzadeh, E. Salehifar, N. Rastkari, S. Khalaj, A. Rezaie and M. Abdollahi, 2005b. Future drugs for treatment of acute respiratory distress syndrome. Int. J. Pharmacol., 1: 9-16.
115. Veness-Meehan, K.A., F.G. Bottone and A.D. Stiles, 2000. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats. Pediatr. Res., 48: 434-444.
116. Vidal, S., A.M. Beluchi, M. Cellier, B. Beatty and P. Gross, 1995. Cloning and characterization of a second human Nramp gene on chromosome 12ql 3. Mamm. Genome., 6: 224-230.
117. Voget, B.A., J. Alam, A.J. Croatt, G.M. Veraallott and K.A. Nath, 1995. Acquired resistance to acute oxidative stress: Possible role of heme oxygenase and ferritin. Lab. Invest., 72: 474-483.
118. Walther, F.J., R. David-Cu and S.L. Lopez, 1995. Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am. J. Physiol. Lung Cell Mol. Physiol., 269: L613-L617.
119. Wessehus, L., M.E. Nelson and B.S. Shikne, 1994. Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers. Am. J. Respir. Crit. Care Med., 150: 690-695.
120. Wesselius, L., W. Wade, K. Baily, S. Vamos, A. O'brien-lander and Th.Weigmann, 1996. Iron uptake promotes hyperoxic injury to Alveolar macrophages. Am. J. Respir. Crit. Care Med., 159: 100-106.
121. Yang, F., J. Coals on, H. Bobb, J. Carter, J. Banu and A. Ghio, 1999. Resistance of hypotransferrinemic mice to hyperoxia-induced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol., 277: L1214-L1223.
122. Yang, F., X. Wang, D J. Haile, C. Piantadosi and A. Ghio, 2002. Iron increases expression of iron-export protein MTP1 in lung cells. Am. J. Physiol. Lung Cell Mol. Physiol., 283: L932-L939.
123. Yang, F., D.J. Haile, X. Wang, L.A. Dailey, J.G. Stronchuerner and A. Ghio, 2005. Apical location of ferroportin 1 in airway epithelia and its role in iron detoxification in the lung. Am. J. Physiol. Lung Cell Mol. Physiol., 289: L14-L23.
124. Zimova-Herknerova, M., J. Myslivekand P. Potmisil, 2008. Retinoic acid attenuates the mild hyperoxic lung injury in newborn mice. Physiol. Res., 57: 33-40.